Post-radiation targeting of TIGIT and CD96 improved immunotherapy efficacy in head and neck squamous cell carcinoma.

Mol Med · 2025 · PMC12801826 · PMID 41382272

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

nearly significantno p-value reported

In these cohorts , TNM stage appeared as the most prominent and only nearly significant independent prognostic factor for survival in TIGIT (HR = 3.45 and q = 0.096) and CD96 (HR = 4.05 and q = 0.085) cohorts.

also in 3,287 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.